Clinical Trial

Sibannac, Inc. and Celebrity Television Personality William Henry Announce First Podcast Interview for Starwalker Cafe and Plant Medicine Travel Destinations

Scottsdale, Arizona--(Newsfile Corp. - January 16, 2025) - Sibannac, Inc. (OTC Pink: SNNC), a Nevada corporation (the "Company"), announced the…

11 months ago

Servier and Google Cloud Expand Partnership on using Data and AI

Servier to leverage Google Cloud AI across R&D, production, and distribution, accelerating digital transformation to benefit patients.These new advancements in…

11 months ago

Aptevo’s Peter Pavlik, PhD, Chairing Session on “Bi and Multispecific Biologics” at Cambridge Healthcare Institute’s Pep Talk 2025

Also giving an in-session talk titled "Modular Multispecific Biotherapeutics: Rapid Therapeutic Design with the ADAPTIR® Platform," showcasing Aptevo's drug engineering…

11 months ago

Metagenomi Announces New Appointment to its Board of Directors

EMERYVILLE, Calif., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing…

11 months ago

Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions

-New FDA Consultant is the former Director of the Division of Imaging, Diagnostics, and Software Reliability at the U.S Food…

11 months ago

Medexus and British Columbia’s Provincial Health Services Authority (PHSA) Successfully Complete Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in British Columbia, Canada

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 15, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed a…

11 months ago

KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter

MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the…

11 months ago

Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the…

11 months ago

BAIBYS™ Announces a Breakthrough in Fertility Treatment with a Newly CE Marked IVF System

The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market TEL AVIV, Israel, Jan. 14, 2025…

11 months ago

BAIBYS™ Announces a Breakthrough in Fertility Treatment with a Newly CE Marked IVF System

The Autonomous Sperm Selection AI-based Robotic System is Poised to Transform the IVF Market TEL AVIV, Israel, Jan. 14, 2025…

11 months ago